| Mar'20 | Dec'19 | Sep'19 | Jun'19 | Mar'19 | Dec'18 | Sep'18 | Jun'18 | Mar'18 |
|---|---|---|---|---|---|---|---|---|
Cash flows from operating activities | ||||||||
Net income | ||||||||
193,867 | 187,067 | 174,492 | 167,590 | 165,668 | 165,676 | 0 | 0 | 0 |
Adjustments to reconcile net income to net cash provided by operating activities | ||||||||
Depreciation | ||||||||
2,730 | 2,630 | 2,641 | 2,648 | 2,596 | 2,658 | 0 | 0 | 0 |
Non-cash expenses | ||||||||
288 | 288 | 105 | 125 | 116 | 177 | 0 | 0 | 0 |
Income from equity method investments | ||||||||
123,647 | 116,747 | 111,411 | 103,888 | 95,922 | 94,361 | 0 | 0 | 0 |
Distributions of earnings received from equity method investments | ||||||||
125,965 | 119,865 | 113,301 | 106,019 | 97,897 | 98,134 | 0 | 0 | 0 |
Changes in operating assets and liabilities | ||||||||
Increase (Decrease) in Accounts Receivable | ||||||||
- | - | - | - | - | - | 0 | 0 | 0 |
Accounts receivable | ||||||||
-918 | 1,782 | 1,119 | 1,302 | 1,022 | 425 | 0 | 0 | 0 |
Prepaid expenses and other current assets | ||||||||
-16 | 484 | -1,272 | 571 | 373 | 3,297 | 0 | 0 | 0 |
Increase (Decrease) in Accounts Payable | ||||||||
- | - | - | - | - | - | 0 | 0 | 0 |
Accounts payable | ||||||||
-1,010 | -2,410 | -544 | 655 | 354 | 854 | 0 | 0 | 0 |
Deferred revenue and credits | ||||||||
1,477 | 477 | 2,297 | 1,444 | -1,147 | 1,067 | 0 | 0 | 0 |
Other current liabilities | ||||||||
-372 | -572 | 1,880 | -98 | 232 | 3,300 | 0 | 0 | 0 |
Net cash provided by operating activities | ||||||||
201,232 | 189,332 | 182,527 | 173,155 | 168,723 | 173,783 | 0 | 0 | 0 |
Cash flows from investing activities | ||||||||
Capital expenditures | ||||||||
1,581 | 1,081 | 638 | 1,398 | 1,719 | 1,604 | 0 | 0 | 0 |
Distributions in excess of earnings from equity method investments | ||||||||
11,138 | 11,538 | 12,603 | 15,239 | 16,800 | 19,670 | 0 | 0 | 0 |
Net cash provided by investing activities | ||||||||
9,557 | 10,457 | -75,265 | -73,389 | -72,149 | -69,164 | 0 | 0 | 0 |
Cash flows from financing activities | ||||||||
Proceeds from issuance of term loan | ||||||||
468,000 | 0 | 0 | 0 | 0 | - | - | - | - |
Distributions to unitholders and general partner | ||||||||
140,737 | 134,737 | 129,381 | 123,609 | 118,698 | 105,928 | 0 | 0 | 0 |
Distributions to non-controlling interests | ||||||||
25,291 | 23,191 | 21,827 | 28,279 | 35,986 | 46,412 | 0 | 0 | 0 |
Net cash used in financing activities | ||||||||
-166,028 | -157,928 | -64,211 | -64,891 | -82,687 | -80,343 | 0 | 0 | 0 |
Net change in cash and cash equivalents | ||||||||
44,761 | 41,861 | 43,051 | 34,875 | 13,887 | 24,276 | 0 | 0 | 0 |
Supplemental cash flow information | ||||||||
Cash paid for interest | ||||||||
15,940 | 16,440 | 12,485 | 12,368 | 8,628 | 735 | 0 | 0 | 0 |
Non-cash investing transactions | ||||||||
Accrued capital expenditures | ||||||||
219 | 219 | 341 | 171 | 166 | 164 | 0 | 0 | 0 |
Proceeds from Issuance of Long-term Debt | ||||||||
0 | - | - | - | 0 | - | - | - | - |